VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $585,000 | +11600.0% | 25,160 | +12480.0% | 0.02% | – |
| Q1 2016 | $5,000 | -75.0% | 200 | 0.0% | 0.00% | – |
| Q4 2015 | $20,000 | -97.6% | 200 | -95.7% | 0.00% | -100.0% |
| Q3 2015 | $838,000 | -19.7% | 4,700 | 0.0% | 0.01% | -6.7% |
| Q2 2015 | $1,044,000 | +11.8% | 4,700 | 0.0% | 0.02% | +7.1% |
| Q1 2015 | $934,000 | +14.5% | 4,700 | -17.5% | 0.01% | +16.7% |
| Q4 2014 | $816,000 | +9.1% | 5,700 | 0.0% | 0.01% | +9.1% |
| Q3 2014 | $748,000 | +4.0% | 5,700 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $719,000 | -4.3% | 5,700 | 0.0% | 0.01% | -8.3% |
| Q1 2014 | $751,000 | – | 5,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |